Goserelin versus danazol in the treatment of endometriosis.

F L Giorgino, Francesco Giorgino, Giorgino FL, C Cetera, Cetera C, G De Laurentiis, de Laurentiis G
Clinical and experimental obstetrics & gynecology · 1991 · vol. 18(2) , pp. 127–31 · PMID:1833094 · W2418028028
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Goserelin and danazol were equally effective in treating endometriosis, but goserelin demonstrated a more favorable therapeutic profile.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Fourteen patients affected by endometriosis were treated by Danazol and by Goserelin. The two treatments were compared. From the study it emerged that both treatments were equally effective; however, the analogs gave a more favourable therapeutic profile.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Buserelin Danazol Endometriosis Pelvic Neoplasms Bone Density Buserelin Buserelin Buserelin Danazol Danazol Endometriosis Female Goserelin Humans Pelvic Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-08-22T06:09:51.966504+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:05.481982+00:00
License: CC0 · commercial use OK